The controversial decision by the United States Preventive Services Task Force (USPSTF) recommending against screening for prostate cancer with the prostate specific antigen (PSA) test has resulted in confusion for patients and physicians alike.Historically...

In May 2012, the United States Preventive Services Task Force finalized a controversial draft statement recommending against routine prostate specific antigen (PSA)-based screening for prostate cancer. Praised by some, and harshly criticized by others,...